Bronchial Thermoplasty in Severe Persistent Asthma
Public ClinicalTrials.gov record NCT01350336. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Post-FDA Approval Clinical Trial Evaluating Bronchial Thermoplasty in Severe Persistent Asthma
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
As Conditions of Approval of the PMA for the Alair System, the FDA requires Boston Scientific to generate data to assess the durability of the BT treatment effect as well as safety data in the intended use population in the United States.
Study identification
- NCT ID
- NCT01350336
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 284 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 6, 2011
- Primary completion
- Nov 11, 2019
- Completion
- Mar 16, 2020
- Last update posted
- Mar 4, 2021
2011 – 2020
United States locations
- U.S. sites
- 23
- U.S. states
- 16
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham Lung Health Center | Birmingham | Alabama | 35294 | — |
| Yale University Center for Asthma and Airway Disease | New Haven | Connecticut | 06520 | — |
| University of Chicago | Chicago | Illinois | 60637 | — |
| University of Iowa | Iowa City | Iowa | 52242 | — |
| LSU Health Sciences | New Orleans | Louisiana | 70112 | — |
| St. Elizabeth's Medical Center | Boston | Massachusetts | 02135 | — |
| Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02215 | — |
| Lahey Clinic | Burlington | Massachusetts | 01805 | — |
| Henry Ford Hospital | Detroit | Michigan | 48202 | — |
| Spectrum Health Hospitals | Grand Rapids | Michigan | 49503 | — |
| HealthPartners Specialty Center, Lung and Sleep Health | Saint Paul | Minnesota | 55103 | — |
| Washington University School of Medicine | St Louis | Missouri | 63110 | — |
| Duke University | Durham | North Carolina | 27710 | — |
| Cleveland Clinic Foundation | Cleveland | Ohio | 44195 | — |
| DuBois Regional Medical Center | DuBois | Pennsylvania | 15801 | — |
| Pennsylvania State Hershey | Hershey | Pennsylvania | 17033 | — |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | — |
| Medical University of South Carolina | Charleston | South Carolina | 29425 | — |
| University of Virginia Medical Center | Charlottesville | Virginia | 22908 | — |
| Pulmonary Associates of Richmond | Richmond | Virginia | 23225 | — |
| Franciscan Research Center (St. Joseph Medical Center) | Tacoma | Washington | 98405 | — |
| MultiCare Pulmonary Specialists | Tacoma | Washington | 98405 | — |
| University of Wisconsin | Madison | Wisconsin | 53792 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.
Recently updated Severe Asthma trials
Other public records listing Severe Asthma. Sorted by last update posted; newest first. Not a recommendation.
- NCT07532265: A Phase 2 Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients With Severe Asthma Recruiting
- NCT07654842: Fasenra: An Asthma Study Not yet recruiting
- NCT06985225: Evaluation of Ventilation Defects Downstream of Mucus Plugs in Patients With Muco-Obstructive Lung Disease Recruiting
- NCT07276724: A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1) Recruiting
- NCT06389058: Using NLP and Neural Networks to Autonomously Identify Severe Asthma and Determine Study Eligibility in a Large Healthcare System Active, not recruiting
- NCT07359846: A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2) Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01350336, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 4, 2021 · Synced Sep 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01350336 live on ClinicalTrials.gov.